Detalles de la búsqueda
1.
Temporal changes in mammographic breast density and breast cancer risk among women with benign breast disease.
Breast Cancer Res
; 26(1): 52, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38532516
2.
Host, reproductive, and lifestyle factors in relation to quantitative histologic metrics of the normal breast.
Breast Cancer Res
; 25(1): 97, 2023 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37582731
3.
Intraluminal tumor cells and prognostic accuracy of endometrial cancer stage criteria: A multi-institution study.
Gynecol Oncol
; 178: 130-137, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37862792
4.
Associations Between Intraluminal Tumor Cell Involvement in Serially Examined Fallopian Tubes and Endometrial Carcinoma Characteristics and Outcomes.
Int J Gynecol Pathol
; 41(5): 520-529, 2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34380972
5.
Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
Int J Gynecol Pathol
; 41(Suppl 1): S64-S89, 2022 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305535
6.
Risk factors for breast cancer development by tumor characteristics among women with benign breast disease.
Breast Cancer Res
; 23(1): 34, 2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33736682
7.
Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.
Histopathology
; 79(2): 160-167, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33432679
8.
Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case-control study.
Int J Cancer
; 147(6): 1535-1547, 2020 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32068253
9.
Universal Testing to Identify Lynch Syndrome Among Women With Newly Diagnosed Endometrial Carcinoma.
J Obstet Gynaecol Can
; 42(2): 137-143, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31679916
10.
Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).
Int J Gynecol Pathol
; 38 Suppl 1: S93-S113, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30550486
11.
FIGO Stage Is the Strongest Prognostic Factor in Adenocarcinoma of the Uterine Cervix.
J Obstet Gynaecol Can
; 41(9): 1318-1324, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31006541
12.
Post-colposcopy Management of ASC-US and LSIL Pap Tests (PALS Trial): Pilot RCT.
J Obstet Gynaecol Can
; 41(7): 916-925, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31230661
13.
The Impact of Gynaecological Tumour Board Rounds on Patient Care.
J Obstet Gynaecol Can
; 41(2): 180-184.e1, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30393059
14.
Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices.
Gynecol Oncol
; 148(3): 515-520, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29395311
15.
Tissue-based Immunohistochemical Biomarker Expression in Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review.
Int J Gynecol Pathol
; 37(2): 128-140, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28582347
16.
Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
Int J Gynecol Pathol
; 37(3): 205-228, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28700433
17.
Cervical Adenocarcinoma: A Comparison of the Reproducibility of the World Health Organization 2003 and 2014 Classifications.
J Low Genit Tract Dis
; 22(2): 132-138, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29474242
18.
Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.
Prev Med
; 98: 15-20, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28279257
19.
Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.
Prev Med
; 98: 5-14, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28279264
20.
Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Int J Gynecol Pathol
; 36(4): 310-322, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27801764